2,4,5-Trisubstituted D2-Thiazolines
FULL PAPER
brated by using the residual peak of the solvent as the internal standard
(CDCl3: CHCl3 dH =7.26 ppm, CDCl3 dC =77.16 ppm; [D6]DMSO:
[D5]DMSO dH =2.5 ppm, [D6]DMSO dC =39.5 ppm). HRMS was per-
formed by using a mass spectrometer with electrospray ionization (ES+);
sodium formate was used as the calibration chemical.
column chromatography on silica gel (heptane/EtOAc 95:5!80:20) to
give (ꢀ)-6 as a yellow noncrystalline solid (145 mg, 60%). 1H NMR
(400 MHz, CDCl3): d=7.34–7.22 (m, 5H), 5.27 (d, J=9.2 Hz, 1H), 5.00
(d, J=7.2 Hz, 1H), 4.75 (dd, J=9.2, 7.2 Hz, 1H), 3.59 (s, 3H), 2.33 (s,
3H), 1.41 ppm (s, 9H); 13C NMR (100 MHz, CDCl3): d=194.0, 170.8,
155.2, 137.6, 128.8 (2C), 128.3 (2C), 128.2, 80.4, 58.2, 52.5, 50.4, 30.5,
28.4 ppm (3C); IR: n˜ =3368, 1747, 1718, 1498, 1164 cmꢁ1; HRMS (ES)
calcd for C17H23NNaO5S: 376.1195 [M+Na]+; found: 376.1196.
Representative procedures
(ꢀ)-(2S,3R)-2,3-Dihydroxy-3-phenylpropionic acid methyl ester ((ꢀ)-2):
Methyl cinnamate (30.83 mmol, 5 g), K2OsO4·2H2O (0.62 mmol, 228 mg),
and 4-methylmorpholine N-oxide (46.25 mmol, 5.42 g) were mixed in ace-
tone/MeCN/H2O (1:1:1, 140 mL) and the reaction was stirred at RT for
16 h. The volatile solvents were removed by evaporation and the remain-
ing mixture was diluted with saturated aqueous NaHCO3 and extracted
with EtOAc. The organic phase was dried (Na2SO4), filtered, and concen-
trated. The crude material was purified by column chromatography on
silica gel (heptane/EtOAc 80:20!50:50) to give (ꢀ)-2 as a colorless oil
(4.9 g, 81%). Spectral data agreed with published results.[31]
(ꢀ)-(2R,3R)-2-Azido-3-(2-cyclopropylacetoxy)-3-phenylpropionic
acid
methyl ester ((ꢀ)-8b): Compound (ꢀ)-4 (0.90 mmol, 200 mg), cyclopro-
pylacetic acid (1.18 mmol, 0.11 mL), and dicyclohexylcarbodiimide
(1.18 mmol, 242 mg) were mixed in CH2Cl2 (8 mL) and DMAP
(1.18 mmol, 144 mg) was added; the reaction was stirred at RT for 1 h.
The reaction mixture was diluted with CH2Cl2 and washed with 2%
aqueous KHSO4. The organic phase was dried (Na2SO4), filtered, and
concentrated. The crude material was purified by column chromatogra-
phy on silica gel (heptane/EtOAc 95:5!85:15) to give (ꢀ)-8b as a color-
less oil (258 mg, 95%). 1H NMR (400 MHz, CDCl3): d=7.41–7.32 (m,
5H), 6.16 (d, J=6.4 Hz, 1H), 4.35 (d, J=6.4 Hz, 1H), 3.76 (s, 3H), 2.28
(d, J=7.2 Hz, 2H), 1.11–0.98 (m, 1H), 0.59–0.51 (m, 2H), 0.20–0.13 ppm
(m, 2H); 13C NMR (100 MHz, CDCl3): d=171.5, 167.8, 135.4, 129.2,
128.7 (2C), 127.2 (2C), 74.5, 65.4, 52.8, 39.4, 6.8, 4.5 ppm (2C); IR: n˜ =
(ꢀ)-(2S,3R)-3-Hydroxy-2-(4-nitrobenzenesulfonyloxy)-3-phenylpropionic
acid methyl ester ((ꢀ)-3): Compound (ꢀ)-2 (26.25 mmol, 5.15 g) was dis-
solved in CH2Cl2 (250 mL) and cooled to 08C in an ice bath. 4-Nitroben-
zenesulfonyl chloride (26.25 mmol, 5.82 g) followed by TEA
(26.25 mmol, 3.66 mL) were added and the reaction was stirred at 08C
for 1 h. The reaction mixture was acidified and then washed with 1m
aqueous HCl (pHꢂ1), dried (Na2SO4), filtered, and concentrated. The
crude material was purified by column chromatography on silica gel
(heptane/EtOAc 90:10!60:40) to give (ꢀ)-3 as a colorless solid (7.5 g,
75%). Spectral data agreed with published results.[25]
2118, 1750 cmꢁ1
: HRMS (ES) calcd for C15H17N3NaO4: 326.1117
[M+Na]+; found: 326.1115.
(ꢀ)-(2R,3R)-2-(2-Cyclopropylacetylamino)-3-hydroxy-3-phenylpropionic
acid methyl ester ((ꢀ)-9b): SnCl2·2H2O (2.25 mmol, 508 mg) was dis-
solved in MeOH/H2O 1:4 (2.5 mL) and (ꢀ)-8b (0.45 mmol, 135 mg) dis-
solved in MeOH (2.5 mL) was added and the reaction was stirred at RT
for 2 h. NaHCO3 (9 mmol, 756 mg) was added in portions to the reaction
mixture and the reaction was stirred at RT for an additional 18 h. The re-
action mixture was filtered through Celite and the Celite was carefully
washed with EtOAc. The organic phase was washed with saturated
NaHCO3, dried (Na2SO4), filtered, and concentrated. The crude material
was purified by column chromatography on silica gel (heptane/EtOAc
80:20!50:50) to give (ꢀ)-9b as a colorless noncrystalline solid (89 mg,
71%). 1H NMR (400 MHz, CDCl3): d=7.27–7.19 (m, 3H), 7.18–7.13 (m,
2H), 6.66–6.58 (m, 1H), 5.18 (d, J=3.6 Hz, 1H), 4.97–4.92 (m, 1H), 4.45
(brs, 1H), 3.65 (s, 3H), 2.07 (d, J=7.6 Hz, 1H), 0.86–0.76 (m, 1H), 0.52–
0.42 (m, 2H), 0.09–0.00 ppm (m, 2H): 13C NMR (100 MHz, CDCl3): d=
174.2, 170.1, 139.2, 128.3 (2C), 128.1, 126.0 (2C), 75.1, 59.1, 52.6, 41.0,
6.9, 4.6 ppm (split, 2C); IR: n˜ =3419, 1743, 1656, 1521 cmꢁ1: HRMS (ES)
calcd for C15H19NNaO4: 300.1212 [M+Na]+; found: 300.1211.
(ꢀ)-(2R,3R)-2-Azido-3-phenyl-3-hydroxypropionic acid methyl ester
((ꢀ)-4): Compound (ꢀ)-3 (7.55 mmol, 2.88 g) and NaN3 (45.3 mmol,
2.94 g) were mixed in dry DMF (13 mL) and the reaction was heated to
408C for 48 h. The reaction mixture was diluted with brine and extracted
with EtOAc, the organic phase was dried (Na2SO4), filtered, and concen-
trated. The crude material was purified by column chromatography on
silica gel (heptane/EtOAc 90:10!60:40) to give (ꢀ)-4 as a colorless non-
1
crystalline solid (1.17 g, 70%). H NMR (400 MHz, CDCl3): d=7.42–7.31
(m, 5H), 5.00 (d, J=7.2 Hz, 1H), 4.10 (d, J=7.2 Hz, 1H), 3.77 (s, 3H),
3.02 ppm (brs, 1H); 13C NMR (100 MHz, CDCl3): d=169.5, 139.0, 128.9,
128.7 (2C), 126.7 (2C), 74.2, 66.9, 52.9 ppm; IR: n˜ =3426, 2117,
1738 cmꢁ1; HRMS (ES) calcd for C10H11N3NaO3: 244.0698 [M+Na]+;
found: 224.0701.
(ꢀ)-(2R,3R)-2-tert-Butoxycarbonylamino-3-hydroxy-3-phenylpropionic
acid methyl ester ((ꢀ)-5): SnCl2·2H2O (22.6 mmol, 5.1 g) was dissolved in
1,4-dioxane/H2O (1:4, 20 mL) and (ꢀ)-4 (4.52 mmol, 1 g) dissolved in 1,4-
dioxane (20 mL) was added. The reaction was stirred at RT for 4 h.
NaHCO3 (4.6 mmol, 386 mg) was added, followed by Boc2O (0.35 mmol,
76 mg), and the reaction was stirred at RT for an additional 16 h. The re-
action mixture was filtered through Celite, and washed with EtOAc. The
organic phase was washed with saturated NaHCO3, dried (Na2SO4), fil-
tered, and concentrated. The crude material was purified by column
chromatography on silica gel (heptane/EtOAc 90:10!60:40) to give (ꢀ)-
5 as a colorless noncrystalline solid (1.24 g, 93%). 1H NMR (400 MHz,
CDCl3): d=7.39–7.24 (m, 5H), 5.34 (d, J=7.2 Hz, 1H), 5.18 (d, J=
2.8 Hz, 1H), 4.77–4.66 (m, 1H), 3.70 (s, 3H), 1.45 ppm (s, 9H); 13C NMR
(100 MHz, CDCl3): d=170.5, 156.4, 139.3, 128.4 (2C), 128.1, 126.1 (2C),
80.7, 75.1, 59.8, 52.5, 28.3 ppm (3C); IR: n˜ =3425, 1744, 1713, 1502,
1368 cmꢁ1; HRMS (ES) calcd for C15H21NNaO5: 318.1317 [M+Na]+;
found: 318.1318.
(ꢀ)-(4S,5S)-2-Cyclopropylmethyl-5-phenyl-4,5-dihydrothiazole-4-carboxyl-
ic acid methyl ester ((ꢀ)-10a): Compound (ꢀ)-9b (0.46 mmol, 126 mg)
and 0.6 (0.28 mmol, 113 mg) or 1 equivalent (0.46 mmol, 186 mg) of the
Lawesson reagent were mixed in toluene (3 mL) and the reaction was
heated at reflux with an oil bath for 1 h. The reaction mixture was diluted
with EtOAc and washed with saturated aqueous NaHCO3. The organic
phase was dried (Na2SO4), filtered, and concentrated. The crude material
was purified by column chromatography on silica gel (heptane/EtOAc
80:20!50:50) to give (ꢀ)-10a as a colorless oil (with 0.6 equivalents of
the Lawesson reagent: 90 mg, 71%; with 1 equivalent of the Lawesson
reagent: 114 mg, 90%). 1H NMR (400 MHz, CDCl3): d=7.26–7.13 (m,
5H), 5.21 (d, J=6.8 Hz, 1H), 5.05–5.01 (m, 1H), 3.68 (s, 3H), 2.45–2.40
(m, 2H), 1.00–0.88 (m, 1H), 0.53–0.45 (m, 2H), 0.20–0.12 ppm (m, 2H);
13C NMR (100 MHz, CDCl3): d=174.9, 170.9, 140.6, 129.0 (2C), 128.2,
127.6 (2C), 85.9, 56.6, 52.9, 39.4, 9.4, 5.2, 5.1 ppm; IR: n˜ =1744, 1619,
1266 cmꢁ1; HRMS (ES) calcd for C15H17NNaO2S: 298.0878 [M+Na]+;
found: 298.0875.
(ꢀ)-(2S,3S)-3-Acetylsulfanyl-2-tert-butoxycarbonylamino-3-phenylpro-
pionic acid methyl ester ((ꢀ)-6): Compound (ꢀ)-5 (0.68 mmol, 200 mg)
was dissolved in CH2Cl2 (8 mL) and cooled to 08C in an ice bath. Ms2O
(0.75 mmol, 131 mg) followed by TEA (1.02 mmol, 0.14 mL) were added
and the reaction was stirred at 08C for 2 h. The reaction mixture was di-
luted with CH2Cl2 and washed with saturated aqueous NH4Cl. The organ-
ic phase was dried (Na2SO4), filtered, and concentrated. The crude mate-
rial was dissolved in dry DMF (8 mL) and potassium thioacetate
(3.4 mmol, 388 mg) was added; the reaction was stirred at RT for 15 h.
The reaction mixture was quenched with 1m aqueous HCl and acidified
to pHꢂ1, then extracted with EtOAc. The organic phase was dried
(Na2SO4), filtered, and concentrated. The crude material was purified by
trans-3-(3-Methoxyphenyl)acrylic acid methyl ester (11b): Trimethyl phos-
phonoacetate (8.20 mmol, 1.33 mL) was dissolved in dry THF (40 mL)
and NaH (9.02 mmol, 216 mg) was added; the reaction was stirred at RT
for 5 min before 3-methoxybenzaldehyde (4.10 mmol, 0.5 mL) was
added. The stirring continued at RT for a further 15 h. THF was evapo-
rated and the crude mixture was diluted with saturated aqueous
NaHCO3 and extracted with EtOAc. The organic phase was dried
(Na2SO4), filtered, and concentrated. The crude material was purified by
column chromatography on silica gel (heptane/EtOAc 95:5!70:30) to
Chem. Eur. J. 2013, 19, 9916 – 9922
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9921